Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors-Reference-Cited by-同舟云学术

Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors

Published:2017-04-07 Issue:16 Volume:123 Page:3150-3158
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Mastellaro Maria J.¹²^ORCID,Seidinger Ana L.³⁴,Kang Guolian⁵,Abrahão Renata⁶,Miranda Eliana C. M.⁷,Pounds Stanley B.⁵^ORCID,Cardinalli Izilda A.⁸,Aguiar Simone S.²⁹,Figueiredo Bonald C.¹⁰,Rodriguez-Galindo Carlos¹¹¹²,Brandalise Silvia R.¹³,Yunes José A.³⁴,Barros-Filho Antônio de A.¹⁴,Ribeiro Raul C.¹¹¹²

Affiliation:

1. Graduate Program in Child and Adolescent Health; School of Medical Sciences, University of Campinas; Campinas Sao Paulo Brazil

2. Pediatric Oncology Department, Boldrini Children's Center; Campinas Sao Paulo Brazil

3. Medical Genetics Department; School of Medical Sciences, University of Campinas; Campinas Sao Paulo Brazil

4. Molecular Biology Laboratory, Boldrini Children's Center, Campinas; Campinas Sao Paulo Brazil

5. Department of Biostatistics; St Jude Children's Research Hospital; Memphis Tennessee

6. Department of Noncommunicable Disease Epidemiology; London School of Hygiene and Tropical Medicine; London United Kingdom

7. Data Center and Statistics; Hematology and Hemotherapy Department, University of Campinas; Campinas Sao Paulo Brazil

8. Department of Pathology; Boldrini Children's Center; Campinas Sao Paulo Brazil

9. Center for Pediatrics Research (CIPED); University of Campinas; Campinas Sao Paulo Brazil

10. Federal University of Parana and Pele Pequeno Principe Research Institute; Curitiba Parana Brazil

11. Department of Global Medicine; International Outreach Program, St Jude Children's Research Hospital; Memphis Tennessee

12. Department of Oncology; St Jude Children's Research Hospital; Memphis Tennessee

13. Department of Oncology and Hematology; Boldrini Children's Center; Campinas Sao Paulo Brazil

14. Department of Pediatrics; School of Medical Sciences, University of Campinas; Campinas Sao Paulo Brazil

Funder

Brazilian National Council for Scientific and Technological Development (www.cnpq.br)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

PROCAD

Cancer Center Support (CORE)

National Institutes of Health

ALSAC

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30703/fullpdf

Reference32 articles.

1. Germ-line p53 mutations predispose to a wide spectrum of early onset cancers;Nichols;Cancer Epidemiol Biomarkers Prev,2001

2. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families;Birch;Cancer Res,1994

3. Relative frequency and morphology of cancers in carriers of germline TP53 mutations;Birch;Oncogene,2001

4. P53 germline mutations in childhood cancers and cancer risk for carrier individuals;Chompret;Br J Cancer,2000

5. The p53 mutation “gradient effect” and its clinical implications;Zambetti;J Cell Physiol,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional pri-miR-34b/c rs4938723 and KRAS 3′UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome?;Gene;2024-03

2. Germline mutations in cancer predisposition genes among pediatric patients with cancer and congenital anomalies;Pediatric Research;2024-01-05

3. Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score—Report from the German MET Studies;Cancers;2022-12-30

4. Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience;Journal of the Endocrine Society;2022-07-26

5. Environmental Contaminants Modulate Breast Cancer Development and Outcome in TP53 p.R337H Carriers and Noncarriers;Cancers;2022-06-19